Gliomas often display mutations in the ARF-MDM2-p53 and p16INK4a-CDK4-RB tumor suppressor pathways resulting in increased genomic instability, loss of G1 cell cycle checkpoint control, and evasion of apoptosis [2, 11]. The gene discussed is TP53; the disease is glioma.